Summary
Both peptides fall into a similar broad context as Neuropeptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Argireline is more often discussed in the realm of Dermatology and aesthetics, whereas Setmelanotide is more often associated with the realm of Metabolic and endocrine. They also influence different molecular systems, with Argireline tracking more closely to SNARE complex while Setmelanotide centers more on Melanocortin receptor. Both are synthetic in origin and their development context also differs, with Argireline cosmetic grade while Setmelanotide is approved. Argireline takes the form of a linear peptide, whereas Setmelanotide is closer to a cyclic peptide, while Argireline carries acetylation features, while Setmelanotide instead reflects d-amino acid substitution changes.